On September 16, 2024, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio), a prominent investment firm, executed a significant transaction by purchasing 372,000 shares of Singular Genomics Systems Inc (NASDAQ:OMIC). This acquisition, marked as a new holding for the firm, was carried out at a price of $12.81 per share, reflecting a strategic move in the healthcare sector. The total shares now held by the firm in OMIC amount to 372,000, representing a 0.48% position in their portfolio and a substantial 14.90% ownership of the company's available stock.
Insight into TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio)
Located at 4747 Executive Drive, San Diego, CA, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) is known for its sharp focus on the healthcare and technology sectors. With an equity portfolio valued at approximately $979 million and 127 stocks under management, the firm has a significant influence in its chosen fields. Top holdings include KalVista Pharmaceuticals Inc (NASDAQ:KALV), AnaptysBio Inc (NASDAQ:ANAB), and several others that underscore its investment philosophy geared towards innovative healthcare solutions.
https://finance.yahoo.com/news/tang-capital-management-llc-acquires-230310149.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.